Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 23;55(1):1901388.
doi: 10.1183/13993003.01388-2019. Print 2020 Jan.

Computed tomography assessment of peripheral traction bronchiolectasis: impact of minimal intensity projection

Constance de Margerie-Mellon  1 , Lisa Belin  2 , Samia Boussouar  3 , Philippe Khafagy  4 , Marie-Pierre Debray  5 , Kim Levand  6 , Marie-Laure Chabi  7 , Antoine Khalil  5 , Amira Benattia  8 , Dominique Israël-Biet  8 , Bruno Crestani  9 , Hilario Nunes  10 , Jacques Cadranel  11 , Philippe Grenier  3 , Dominique Valeyre  10 , Jean-Marc Naccache  11 , Pierre-Yves Brillet  6
Affiliations
Free article

Computed tomography assessment of peripheral traction bronchiolectasis: impact of minimal intensity projection

Constance de Margerie-Mellon et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: C. de Margerie-Mellon reports grants from Institut Servier and Olea Medical, outside the submitted work. Conflict of interest: L. Belin has nothing to disclose. Conflict of interest: S. Boussouar has nothing to disclose. Conflict of interest: P. Khafagy has nothing to disclose. Conflict of interest: M-P. Debray reports personal fees and non-financial support for lectures and meeting attendance from Boehringer Ingelheim and Roche, outside the submitted work. Conflict of interest: K. Levand has nothing to disclose. Conflict of interest: M-L. Chabi has nothing to disclose. Conflict of interest: A. Khalil has nothing to disclose. Conflict of interest: A. Benattia has nothing to disclose. Conflict of interest: D. Israël-Biet has nothing to disclose. Conflict of interest: B. Crestani reports personal fees and non-financial support from AstraZeneca, grants, personal fees and non-financial support from Boehringer Ingelheim and grants from MedImmune, personal fees from Sanofi, outside the submitted work. Conflict of interest: H. Nunes reports grants and personal fees for consultancy and research from Roche/Genentech, grants and personal fees for research from Boehringer Ingelheim, outside the submitted work. Conflict of interest: J. Cadranel has nothing to disclose. Conflict of interest: P. Grenier has nothing to disclose. Conflict of interest: D. Valeyre reports personal fees for advisory board work and meeting attendance from Boehringer Ingelheim and Roche, outside the submitted work. Conflict of interest: J-M. Naccache has nothing to disclose. Conflict of interest: P-Y. Brillet has received personal fees for teaching actions from Boehringer Ingelheim and Roche.

Publication types